Home
Press Journals
Catalog Peptides Market to Reach $332.1 Million by 2024

Catalog Peptides Market to Reach $332.1 Million by 2024

Published: August 2019

The global catalog peptides market is expected to generate $332.1 million revenue by 2024, advancing at a CAGR of 5.8% during the forecast period. Some of the key factors driving the market growth include increasing research activities to address unmet medical needs in various therapeutic areas, growing burden of chronic diseases, and increasing investments and funding for protein-based research, according to P&S Intelligence.

Insights into Market Segments

On the basis of type, the catalog peptides market has been categorized into cyclic, calcitonin gene-related, caspase related, amyloid, adrenomedullin, amylin, tau, cosmetic, anti-microbial, G-protein-coupled receptor (GPCR), and others. Among these, the cyclic peptides category is projected to lead the market, both in terms of revenue and growth, throughout the analysis period. The category is expected to progress at a CAGR of 6.8% during the forecast period, mainly on account of the fact that these peptides provide good stability, high binding affinity, and selectivity toward target biomolecules.

Based on application, the catalog peptides market has been categorized into commercial, academic research, and therapeutics applications. The commercial application category is further classified into antibody production, drug discovery, enzyme profiling, and others.

Among the various commercial applications of catalog peptides, the antibody production category contributed the highest share, of 52.7%, to the market in 2018. It is also expected to be the fastest growing category in the catalog peptides market during the forecast period. This can be attributed to the effectiveness of catalog peptides in raising high-quality antibodies. In addition, they provide several benefits, such as flexibility in antigen selection, low probability of cross-reactivity, and cost-effectiveness.

The academic research application category in the catalog peptides market is further classified into disease research, biomarker discovery, and others. Among these, the disease research category exhibited the largest share, of 58.5%, in 2018, in the market, owing to the extensive use of catalog peptides to address unmet needs in various therapeutic areas, including oncology, cardiovascular diseases, and metabolic disorders.

North America to Lead the Global Catalog Peptides Market

Globally, the North American catalog peptides market is expected to account for more than 30% share by 2024. This can be mainly attributed to the presence of established players, increase in the adoption of advance peptide production technologies, and rise in the investment and funding for research and development (R&D) in the region.
The U.S. is expected to lead the North American catalog peptides market throughout the analysis period. This can be mainly attributed to the increasing demand for peptide-based therapeutics for treating chronic conditions, well-developed R&D infrastructure, and large number of approved Food and Drug Administration (FDA) products in the country.

Catalog Peptides Market Competitive landscape

The global catalog peptides market is fragmented in nature with the presence of various players such as PolyPeptide Group, CSBio, GL Biochem (Shanghai) Ltd., CPC Scientific Inc., Auspep Pty Ltd., Peptides International Inc., Applied Biological Materials (ABM) Inc., Biomatik Corporation, Bio-Synthesis Inc., Thermo Fisher Scientific Inc., GenScript Biotech Corporation, Bachem AG, JPT Peptide Technologies GmbH, Advanced ChemTech, LifeTein LLC, Kaneka Eurogentec S.A., Elim Biopharm Inc., Creative Peptides, Abbiotec Inc., NovoPro Bioscience Inc., KareBay Biochem Inc., Ontores Biotechnologies Inc., Severn Biotech Ltd., Genway Biotech Inc., Kaneka Corporation, New England Peptide Inc., AnaSpec Inc., AAPPTec LLC, and Merck KGaA.

Browse report overview with detailed TOC on "Catalog Peptides Market Research Report: By Type (Cyclic, Calcitonin Gene-Related, Caspase Related, Amyloid, Adrenomedullin, Amylin, Tau, Cosmetic, Anti-Microbial, GPCR), Application (Commercial, Academic Research, Therapeutics), End-User, Geographical Outlook (U.S., Canada, Germany, France, U.K., Italy, Spain, China, Japan, India, South Korea, Singapore, Brazil, Mexico, Israel, South Africa, Saudi Arabia) – Global Industry Size, Share Analysis and Growth Forecast to 2024" at:https://www.psmarketresearch.com/market-analysis/catalog-peptides-market

Among these players, Bachem AG, Thermo Fisher Scientific Inc., Merck KGaA, and AnaSpec Inc. are the key players occupying major share in the catalog peptides market. This is mainly on the account of their large product portfolio of catalog peptides, which are being used for various applications such as antibody production, drug discovery, enzyme profiling, disease research, and biomarker discovery. Additionally, these players offer services related to customize peptides.

CATALOG PEPTIDES MARKET SEGMENTATION

Market Segmentation by Type

Cyclic
Calcitonin gene-related
Caspase related
Amyloid
Adrenomedullin
Amylin
Tau
Cosmetic
Anti-microbial
G-protein-coupled receptors (GPCR)
Others

Market Segmentation by Application

Commercial
- Antibody production
- Drug discovery
- Enzyme profiling
- Others
Academic Research
- Disease research
  - Cancer and apoptosis
  - Cardiovascular
  - Diabetes
  - Neuroscience
  - Infectious diseases
  - Anti-inflammatory
  - Blood disorders
  - Others
- Biomarker discovery
- Others
Therapeutics

Market Segmentation by End User

Pharmaceutical and Biotechnology Companies
Contract manufacturing organizations (CMOs) and Contract research organizations (CROs)
Academic and Research Institutes

Market Segmentation by Geography

North America Catalog Peptides Market
- By type
- By application
- By end user
- By country
  - U.S. catalog peptides market
    - By type
    - By application
    - By end user
  - Canada catalog peptides market
    - By type
    - By application
    - By end user
Europe Catalog Peptides Market
- By type
- By application
- By end user
- By country
  - Germany catalog peptides market
    - By type
    - By application
    - By end user
  - France catalog peptides market
    - By type
    - By application
    - By end user
  - U.K. catalog peptides market
    - By type
    - By application
    - By end user
  - Italy catalog peptides market
    - By type
    - By application
    - By end user
  - Spain catalog peptides market
    - By type
    - By application
    - By end user
Asia-Pacific (APAC) Catalog Peptides Market
- By type
- By end user
- By application
- By country
  - China catalog peptides market
    - By type
    - By application
    - By end user
  - Japan catalog peptides market
    - By type
    - By application
    - By end user
  - India catalog peptides market
    - By type
    - By application
    - By end user
  - South Korea catalog peptides market
    - By type
    - By application
    - By end user
  - Singapore catalog peptides market
    - By type
    - By application
    - By end user
Latin America (LATAM) Catalog Peptides Market
- By type
- By application
- By end user
- By country
  - Brazil catalog peptides market
    - By type
    - By application
    - By end user
  - Mexico catalog peptides market
    - By type
    - By application
    - By end user
Middle East and Africa (MEA) Catalog Peptides Market
- By type
- By application
- By end user
- By country
  - Israel catalog peptides market
    - By type
    - By application
    - By end user
  - South Africa catalog peptides market
    - By type
    - By application
    - By end user
  - Saudi Arabia catalog peptides market
    - By type
    - By application
    - By end user